Ross W Paterson,for the UCL Queen Square National Hospital for Neurology and Neurosurgery COVID-19 Study Group,Rachel L Brown,Laura Benjamin,Ross Nortley,Sarah Wiethoff,Tehmina Bharucha,Dipa L Jayaseelan,Kumar,Rhian E Raftopoulos,Laura Zambreanu,Vinojini Vivekanandam,Anthony Khoo,Ruth Geraldes,Krishna Chinthapalli,Elena Boyd,Hatice Tuzlali,Gary Price,Gerry Christofi,Jasper Morrow,Patricia McNamara,Benjamin McLoughlin,Soon Tjin Lim,Puja R Mehta,Viva Levee,Stephen Keddie,Wisdom Yong,S Anand Trip,Alexander J M Foulkes,Gary Hotton,Thomas D Miller,Alex D Everitt,Christopher Carswell,Nicholas W S Davies,Michael Yoong,David Attwell,Jemeen Sreedharan,Eli Silber,Jonathan M Schott,Arvind Chandratheva,Richard J Perry,Robert Simister,Anna Checkley,Nicky Longley,Simon F Farmer,Francesco Carletti,Catherine Houlihan,Maria Thom,Michael P Lunn,Jennifer Spillane,Robin Howard,Angela Vincent,David J Werring,Chandrashekar Hoskote,Hans Rolf Jäger,Hadi Manji,Michael S Zandi,Guru Kumar

Abstract:Abstract Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders. Detailed clinical and paraclinical data were collected from cases where the diagnosis of COVID-19 was confirmed through RNA PCR, or where the diagnosis was probable/possible according to World Health Organization criteria. Of 43 patients, 29 were SARS-CoV-2 PCR positive and definite, eight probable and six possible. Five major categories emerged: (i) encephalopathies (n = 10) with delirium/psychosis and no distinct MRI or CSF abnormalities, and with 9/10 making a full or partial recovery with supportive care only; (ii) inflammatory CNS syndromes (n = 12) including encephalitis (n = 2, para- or post-infectious), acute disseminated encephalomyelitis (n = 9), with haemorrhage in five, necrosis in one, and myelitis in two, and isolated myelitis (n = 1). Of these, 10 were treated with corticosteroids, and three of these patients also received intravenous immunoglobulin; one made a full recovery, 10 of 12 made a partial recovery, and one patient died; (iii) ischaemic strokes (n = 8) associated with a pro-thrombotic state (four with pulmonary thromboembolism), one of whom died; (iv) peripheral neurological disorders (n = 8), seven with Guillain-Barré syndrome, one with brachial plexopathy, six of eight making a partial and ongoing recovery; and (v) five patients with miscellaneous central disorders who did not fit these categories. SARS-CoV-2 infection is associated with a wide spectrum of neurological syndromes affecting the whole neuraxis, including the cerebral vasculature and, in some cases, responding to immunotherapies. The high incidence of acute disseminated encephalomyelitis, particularly with haemorrhagic change, is striking. This complication was not related to the severity of the respiratory COVID-19 disease. Early recognition, investigation and management of COVID-19-related neurological disease is challenging. Further clinical, neuroradiological, biomarker and neuropathological studies are essential to determine the underlying pathobiological mechanisms that will guide treatment. Longitudinal follow-up studies will be necessary to ascertain the long-term neurological and neuropsychological consequences of this pandemic.

Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition)

Chinese Expert Consensus on the Perinatal and Neonatal Management for the Prevention and Control of the 2019 Novel Coronavirus Infection (first Edition)

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists

Chinese expert consensus on clinical treatment of adult patients with severe traumatic brain injury complicated by corona virus disease 2019 (version 2023)

CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic

Neurological and Psychiatric Presentations Associated with COVID-19

2023 Chinese Expert Consensus on the Impact of COVID-19 on the Management of Cardiovascular Diseases

The Experience of Diagnosis and Treatment of Neurological Diseases Combined with Coronavirus Disease 2019: Analysis of Five Cases

Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study

The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases

Controversies in COVID-19: Diagnostic Evaluation and Management in Neuro-COVID

Neurological Manifestations of Patients with COVID-19: Potential Routes of SARS-CoV-2 Neuroinvasion from the Periphery to the Brain

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Prevention and Control of COVID-19 Infection in a Chinese Mental Health Center

Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China

Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

The Neurological Implications of COVID-19: A Comprehensive Narrative Review

Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations From Society for Neuroscience in Anesthesiology and Critical Care (SNACC)

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions

Neurological Complications of COVID-19: Unraveling the Pathophysiological Underpinnings and Therapeutic Implications

A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management